Cordatus Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $366K | Buy |
|
|||||
|
2025
Q3 | $362K | Buy |
|
|||||
|
2025
Q2 | $323K | Buy |
|
|||||
|
2025
Q1 | $283K | Buy |
|
|||||
|
2024
Q4 | $338K | Buy |
|
|||||
|
2024
Q3 | $284K | Sell |
|
|||||
|
2024
Q2 | $341K | Sell |
|
|||||
|
2024
Q1 | $344K | Sell |
|
|||||
|
2023
Q4 | $331K | Sell |
|
|||||
|
2023
Q3 | $286K | Sell |
|
|||||
|
2023
Q2 | $245K | Buy |
|